These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4260677)

  • 1. Nicotinamide ineffective in parkinsonism.
    Cotzias GC; Lawrence WH; Papavasiliou PS; Düby SE
    N Engl J Med; 1972 Jul; 287(3):147. PubMed ID: 4260677
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenatine treatment of parkinsonism].
    Braĭko IV
    Vrach Delo; 1973 Jul; 7(7):107. PubMed ID: 4271162
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA; Magee KR
    Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
    [No Abstract]   [Full Text] [Related]  

  • 5. Tryptophan-nicotinamide combination in the treatment of newly admitted depressed patients.
    Chouinard G; Young SN; Annable L; Sourkes TL; Kiriakos RZ
    Commun Psychopharmacol; 1978; 2(4):311-7. PubMed ID: 153217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

  • 7. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toloxatone, parkinsonism and dopa therapy].
    Cantagrel A; Dordain G; Dostert P
    Therapie; 1986; 41(6):493-7. PubMed ID: 3810545
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinamide and tetracycline therapy of bullous pemphigoid.
    Fivenson DP; Breneman DL; Rosen GB; Hersh CS; Cardone S; Mutasim D
    Arch Dermatol; 1994 Jun; 130(6):753-8. PubMed ID: 8002646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ergot derivative lisuride in Parkinson's disease.
    Suchy I; Horowski R
    Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
    Jenkins AC; Schwieger AC
    Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of parkinsonism with L-dopa (study of 105 patients).
    Klawans HL; Garvin JS
    Dis Nerv Syst; 1969 Nov; 30(11):737-46. PubMed ID: 5359046
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A
    Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood pressure effects of apomorphine and domperidone in parkinsonism.
    Pollak P; Mallaret M; Gaio JM; Hommel M; Perret J
    Adv Neurol; 1987; 45():263-6. PubMed ID: 3548261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary note on the use of nicotinamide in the treatment of schizophrenia].
    Magalhães MB
    Resen Clin Cient; 1969; 38(11):295-6. PubMed ID: 4254730
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nicotinamide on neurohumoral regulation and lipid peroxidation in ischemic heart disease].
    Gubachev IuM; Vinokur VA; Dornichev VM
    Sov Med; 1988; (1):13-6. PubMed ID: 2834830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical observations on the activity of phosphatidylcholine, thiamine, riboflavin and nicotinamide in chronic liver diseases].
    Cairella M; Venditti A
    Clin Ter; 1969 Aug; 50(4):323-55. PubMed ID: 4245660
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.